Shandong Weigao Group Medical Polymer Co Ltd - Class H

HKSE:01066 (China)   Class H
HK$ 5.10 (+0.99%) Apr 26
10.60
P/B:
0.94
Market Cap:
HK$ 23.06B ($ 2.95B)
Enterprise V:
HK$ 19.42B ($ 2.48B)
Volume:
8.06M
Avg Vol (2M):
9.25M
Also Trade In:
Volume:
8.06M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Shandong Weigao Group Medical Polymer Co Ltd ( ) from 2004 to Apr 26 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shandong Weigao Group Medical Polymer stock (HKSE:01066) PE ratio as of Apr 26 2024 is 10.6. More Details

Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) PE Ratio (TTM) Chart

To

Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) PE Ratio (TTM) Historical Data

Total 1193
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Shandong Weigao Group Medical Polymer PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-04-26 10.6 2024-02-20 10.4
2024-04-25 10.5 2024-02-19 9.8
2024-04-24 10.3 2024-02-16 9.9
2024-04-23 10.4 2024-02-15 9.8
2024-04-22 10.1 2024-02-14 9.8
2024-04-19 9.9 2024-02-09 9.9
2024-04-18 9.9 2024-02-08 10.3
2024-04-17 9.9 2024-02-07 10.3
2024-04-16 10.0 2024-02-06 10.5
2024-04-15 10.0 2024-02-05 10.1
2024-04-12 9.9 2024-02-02 10.6
2024-04-11 9.8 2024-02-01 11.1
2024-04-10 9.7 2024-01-31 10.4
2024-04-09 9.7 2024-01-30 11.3
2024-04-08 9.5 2024-01-29 11.7
2024-04-05 9.4 2024-01-26 11.5
2024-04-03 9.9 2024-01-25 11.8
2024-04-02 10.2 2024-01-24 11.8
2024-03-28 10.2 2024-01-23 11.9
2024-03-27 10.4 2024-01-22 11.3
2024-03-26 9.7 2024-01-19 11.8
2024-03-25 10.1 2024-01-18 12.2
2024-03-22 10.4 2024-01-17 12.3
2024-03-21 11.0 2024-01-16 12.7
2024-03-20 10.6 2024-01-15 12.7
2024-03-19 10.5 2024-01-12 12.9
2024-03-18 10.7 2024-01-11 13.0
2024-03-15 10.6 2024-01-10 13.2
2024-03-14 10.5 2024-01-09 13.8
2024-03-13 10.4 2024-01-08 13.0
2024-03-12 10.6 2024-01-05 14.9
2024-03-11 10.3 2024-01-04 15.0
2024-03-08 10.2 2024-01-03 14.7
2024-03-07 10.0 2024-01-02 15.4
2024-03-06 10.2 2023-12-29 15.8
2024-03-05 10.2 2023-12-28 15.6
2024-03-04 10.5 2023-12-27 12.5
2024-03-01 10.5 2023-12-22 12.8
2024-02-29 10.6 2023-12-21 12.7
2024-02-28 10.4 2023-12-20 12.4
2024-02-27 10.8 2023-12-19 12.3
2024-02-26 10.6 2023-12-18 12.5
2024-02-23 10.7 2023-12-15 12.8
2024-02-22 10.7 2023-12-14 12.5
2024-02-21 10.8 2023-12-13 12.4

Shandong Weigao Group Medical Polymer Co Ltd (HKSE:01066) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Shandong Weigao Group Medical Polymer Co Ltd functions in the healthcare sector in China. Its business mainly involves the research and development, production, and sale of single-use medical device products. The company's segments include Medical device products, Orthopaedic products, Interventional products, Pharma packaging products, Blood management products, and others. The company's products comprise consumables including infusion sets, syringes, medical needles, blood bags, prefilled syringes, wound management, blood sampling products; orthopedic materials, and blood purification consumables and equipment. The company operates in the People's Republic of China, the United States, Europe, the Middle East, and Africa, Asia, and others.